2005
DOI: 10.2214/ajr.185.1.01850265
|View full text |Cite
|
Sign up to set email alerts
|

Papillary Glioneuronal Tumor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
16
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(17 citation statements)
references
References 7 publications
1
16
0
Order By: Relevance
“…Follow‐up data indicate a benign outcome with no evidence of recurrence during intervals ranging from 3 months to 7 years (Table 1). 2–12,15 Histopathological features of papillary glioneuronal tumor are similar in all reported cases, invariably reproducing the first description of this tumor by Komori 2…”
Section: Discussionsupporting
confidence: 80%
See 1 more Smart Citation
“…Follow‐up data indicate a benign outcome with no evidence of recurrence during intervals ranging from 3 months to 7 years (Table 1). 2–12,15 Histopathological features of papillary glioneuronal tumor are similar in all reported cases, invariably reproducing the first description of this tumor by Komori 2…”
Section: Discussionsupporting
confidence: 80%
“…Typical morphological features are pseudopapillary structures composed of frequently thickened hyalinized blood vessels lined by uniform small astrocytes and a proliferation of neurocytic cells eventually admixed with ganglioid and ganglion cells. Rabdoid, minigemistocytic, and Olig2 (a recently established oligodendroglial marker) positive cells have been recognized too 1–16 …”
Section: Introductionmentioning
confidence: 99%
“…PGNT was first described by Komori et al in 1998 in a series of 9 cases 3 . After that, about 33 cases were reported in succession in the English language literature 5–30 . In 2007, WHO classified PGNT as a Grade I neuronal‐glial tumor because of the characteristic papillary architecture and bipartite (astrocytic and neuronal/neurocytic) cell populations.…”
Section: Discussionmentioning
confidence: 99%
“…(b) The solid component of the tumor is formed by sheets of Syn-positive neurocytes, large neurons, and intermediate size "ganglioid" cells. 1,[47][48][49] Gliofibrillary background in the intervening areas shows GFAP-positive staining.…”
Section: Hyalinized Vesselsmentioning
confidence: 99%